ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DOUGLAS BROWN MD

Neurology

325

$89.5K

70
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$275
Average prescription price

Avg: $324

JON GRUDEM MD

Neurology

390

$138K

62
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$354
Average prescription price

Avg: $324

ROBERT MACLACHLAN M.D.

Neurology

468

$305K

56
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$651
Average prescription price

Avg: $324

LUIS PARY MD

Neurology

580

$264K

84
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$455
Average prescription price

Avg: $324

JENNIFER PARY MD

Neurology

589

$136K

92
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$231
Average prescription price

Avg: $324

JENNIFER KRUGER MD

Neurology

912

$137K

128
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$151
Average prescription price

Avg: $324

WILLIAM ANDREWS M.D.

Neurology

1,034

$179K

147
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$174
Average prescription price

Avg: $324

JAMES CASE MD

Neurology

1,123

$741K

113
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$660
Average prescription price

Avg: $324

BRIAN TSCHIDA MD

Neurology

1,446

$371K

169
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 23%

$256
Average prescription price

Avg: $324

RENE MOSADA M.D.

Neurology

1,529

$185K

182
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$121
Average prescription price

Avg: $324

KAREN GARNAAS MD

Neurology

1,573

$816K

202
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 23%

$519
Average prescription price

Avg: $324

ROBERT FINLEY MD

Neurology

1,584

$758K

185
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$478
Average prescription price

Avg: $324

BASSEL SALEM MD

Neurology

1,736

$178K

221
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$103
Average prescription price

Avg: $324

STEVEN HATA MD

Neurology

1,887

$293K

133
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 23%

$155
Average prescription price

Avg: $324

LISA VIOLA DO

Neurology

1,893

$952K

218
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$503
Average prescription price

Avg: $324

MEI HE M.D.

Neurology

1,926

$569K

195
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$295
Average prescription price

Avg: $324

CAROL MILES MD

Neurology

2,119

$322K

244
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$152
Average prescription price

Avg: $324

WILLIAM ROSSING MD

Neurology

2,215

$889K

274
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$401
Average prescription price

Avg: $324

WARREN OPHEIM MD

Neurology

2,258

$535K

239
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$237
Average prescription price

Avg: $324

MATTHEW SIMMONS MD

Neurology

2,503

$860K

170
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$344
Average prescription price

Avg: $324

TODD ZIMPRICH MD

Neurology

2,769

$950K

326
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$343
Average prescription price

Avg: $324

JEROME FREEMAN MD

Neurology

4,056

$1.64M

326
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$405
Average prescription price

Avg: $324

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank